TradingAgents AISign inGet started
All stock profiles
CBUSNASDAQHealthcare

CIBUS INC

Public company snapshot, recent ticker-linked headlines, and a path into evidence-backed AI research.

Latest price

$1.29

-4.44%

Alpha Vantage · 10/30/2026

Industry: BiotechnologyCategory: Domestic Common StockCurrency: USDNews: 0 recent
Analyze CBUS free

One-year price history

Adjusted daily closes · 252 observations · as of Oct 30, 2026

Historical data, not a forecast

1 month

-20.9%

3 months

-31.8%

6 months

-11.0%

1 year

-16.2%

Year to date

-25.9%

52-week range

$1.16 – $4.05

Fundamental snapshot

Latest reported period: Jun 30, 2026

Sharadar reported data

Market cap

$98.6M

P/E

-1

P/B

6.7

P/S

22.7

Revenue

$4.35M

Net income

-$98.19M

Diluted EPS

-1.63

Gross margin

100.00%

Net margin

-2258.90%

Return on equity

-320.60%

Total debt

$286.26M

Cash

$20.43M

Free cash flow

-$46.28M

Latest eight reported quarters

Reported quarterly values, newest first

PeriodRevenueNet incomeGross marginNet marginFree cash flow
Jun 30, 2026$994K-$22.15M100.00%-2227.90%-$9.37M
Mar 31, 2026$1.68M-$21.22M100.00%-1262.50%-$11.56M
Dec 31, 2025$1.06M-$31.29M100.00%-2959.90%-$13.51M
Sep 30, 2025$615K-$23.54M100.00%-3827.80%-$11.85M
Jun 30, 2025$933K-$25.37M100.00%-2719.40%-$13.7M
Mar 31, 2025$1.03M-$46.89M100.00%-4534.40%-$12.12M
Dec 31, 2024$1.21M-$23.1M100.00%-1906.10%-$14.05M
Sep 30, 2024$1.67M-$179.97M100.00%-10795.90%-$13.88M

Reported figures can reflect company reporting conventions, restatements, or sector-specific accounting. Verify against filings before relying on a valuation comparison.

Recent CBUS news

All market news

No ticker-linked stories are in the current archive.